anmelden
NYSE International 100
11.166,01
PKT
-47,23
PKT
-0,42
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu NYSE International 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 01.05.20 | Shell (ex Royal Dutch Shell) Outperform | Credit Suisse Group | |
| 01.05.20 | Nokia Equal weight | Barclays Capital | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | Jefferies & Company Inc. | |
| 01.05.20 | Lloyds Banking Group buy | UBS AG | |
| 01.05.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 01.05.20 | Orange Equal weight | Barclays Capital | |
| 01.05.20 | AstraZeneca overweight | Barclays Capital | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Equal weight | Barclays Capital | |
| 01.05.20 | Orange Outperform | Credit Suisse Group | |
| 01.05.20 | Allianz buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Nokia Neutral | Credit Suisse Group | |
| 01.05.20 | Barclays buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Hold | HSBC | |
| 01.05.20 | Mercedes-Benz Group (ex Daimler) Hold | Deutsche Bank AG | |
| 01.05.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 01.05.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 01.05.20 | Allianz overweight | JP Morgan Chase & Co. | |
| 30.04.20 | Deutsche Bank Verkaufen | Independent Research GmbH | |
| 30.04.20 | Mercedes-Benz Group (ex Daimler) Hold | Warburg Research | |
| 30.04.20 | Santander Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 30.04.20 | BBVA Outperform | RBC Capital Markets | |
| 30.04.20 | Mercedes-Benz Group (ex Daimler) Halten | Independent Research GmbH | |
| 30.04.20 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 30.04.20 | Lloyds Banking Group Outperform | RBC Capital Markets | |
| 30.04.20 | Lloyds Banking Group Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | GSK Underweight | Barclays Capital | |
| 30.04.20 | GSK buy | UBS AG | |
| 30.04.20 | GSK Neutral | Credit Suisse Group | |
| 30.04.20 | Deutsche Bank Underperform | Credit Suisse Group | |
| 30.04.20 | AstraZeneca Outperform | Credit Suisse Group | |
| 30.04.20 | Lloyds Banking Group buy | UBS AG | |
| 30.04.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 30.04.20 | Nokia Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | Deutsche Telekom buy | UBS AG | |
| 30.04.20 | Shell (ex Royal Dutch Shell) Neutral | JP Morgan Chase & Co. | |
| 30.04.20 | Shell (ex Royal Dutch Shell) buy | UBS AG | |
| 30.04.20 | Nokia buy | UBS AG | |
| 30.04.20 | Orange buy | UBS AG |
